Home » Research » Programmes » The Translational Research & Enterprise Accelerator Committee (TREACC)

The Translational Research & Enterprise Accelerator Committee (TREACC)

Clinical translation is dependent upon a wide range of stakeholders and financial, structural, regulatory, commercial and behavioural factors. The Translational Research & Enterprise Accelerator Committee (TREACC) brings together resource holders with experience in all of the above. This novel concept aims to develop a full understanding of barriers to inform portfolio and pathway management at the earliest experimental stage. This will enable priorities to be set, hurdles to be identified early, stop-go decisions to be expedited, and measures put in place to smooth the translational path thereby de-risking the project for further investment. The generation of this evidence base will feed into the UCL hosted Centre for the Advancement of Sustainable Medical Innovation (CASMI) which will act as a vehicle to address some of the policy and regulatory barriers encountered and undertake research as appropriate to address questions regarding the translational/innovation pathway.

The Therapeutic Innovation Networks (TINs) and TREACC will allow us to better align with the Industrial Strategy as well as the Accelerated Access Review making UCLH BRC and its partners the ‘go-to’ place for organizations who wish to partner with academia/hospitals in the areas of Research, Education, Innovation & Industrial Engagement along the whole value chain of therapeutic development. The TIN & TREACC knowledge will directly feed into supporting funding schemes such as Collaborate to Innovate as well as the Enterprise Europe Network both directly targeted at linking SME’s to the academic/BRC/NHS translational infrastructure.

UCLH BRC and its partners have strived to put in place flexible, professional and responsive structures that are highly networked and aligned to deliver a step-fold change in delivering biomedical translational impact.